# The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine

> **NCT06853665** · PHASE4 · RECRUITING · sponsor: **Gagan Joshi** · enrollment: 196 (estimated)

## Conditions studied

- Attention Deficit Hyperactivity Disorder (ADHD)
- Autism
- Autism Spectrum Disorder

## Interventions

- **DRUG:** Adderall XR (mixed salts amphetamine)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06853665
- **Lead sponsor:** Gagan Joshi
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2030-02-01
- **Final completion:** 2030-02-01
- **Target enrollment:** 196 (ESTIMATED)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06853665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06853665, "The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06853665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*